Surgery Partners, Inc.
SGRY
$13.97
$0.191.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 810.90M | 885.00M | 821.50M | 826.20M | 776.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 810.90M | 885.00M | 821.50M | 826.20M | 776.00M |
| Cost of Revenue | 650.70M | 672.80M | 626.20M | 630.60M | 614.10M |
| Gross Profit | 160.20M | 212.20M | 195.30M | 195.60M | 161.90M |
| SG&A Expenses | 39.30M | 23.70M | 22.40M | 36.10M | 36.00M |
| Depreciation & Amortization | 38.50M | 59.90M | 39.50M | 40.30M | 36.30M |
| Other Operating Expenses | -1.70M | -4.90M | -1.70M | -2.10M | -- |
| Total Operating Expenses | 726.80M | 751.50M | 686.40M | 704.90M | 686.40M |
| Operating Income | 84.10M | 133.50M | 135.10M | 121.30M | 89.60M |
| Income Before Tax | -3.30M | 42.60M | 30.80M | 43.80M | -300.00K |
| Income Tax Expenses | -1.20M | 13.60M | 5.50M | -1.10M | -- |
| Earnings from Continuing Operations | -2.10M | 29.00M | 25.30M | 44.90M | -300.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -33.80M | -44.00M | -48.00M | -47.40M | -37.40M |
| Net Income | -35.90M | -15.00M | -22.70M | -2.50M | -37.70M |
| EBIT | 84.10M | 133.50M | 135.10M | 121.30M | 89.60M |
| EBITDA | 122.60M | 193.40M | 174.60M | 161.60M | 125.90M |
| EPS Basic | -0.28 | -0.12 | -0.18 | -0.02 | -0.30 |
| Normalized Basic EPS | -0.17 | 0.01 | -0.06 | -0.08 | -0.13 |
| EPS Diluted | -0.28 | -0.12 | -0.18 | -0.02 | -0.30 |
| Normalized Diluted EPS | -0.17 | 0.01 | -0.06 | -0.08 | -0.13 |
| Average Basic Shares Outstanding | 128.37M | 128.03M | 127.21M | 126.98M | 126.60M |
| Average Diluted Shares Outstanding | 128.37M | 128.03M | 127.21M | 126.98M | 126.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |